Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline
Clinical trial NCT00667121 · COMPLETED
Trial details
- NCT number
- NCT00667121
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-03-16
- Primary completion
- 2014-05-12
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.